Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium measurement, urine |
Component |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine potassium output measurement |
Component |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 7.5% syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate+potassium chloride effervescent tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium phosphate injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium phosphate 2mmol/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium phosphate 2mmol/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium acid phosphate injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium acid phosphate 10mmol/10mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 4%/0.18% 13.5mmol/500mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ringers infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride strong 15% injection+plastic snaps (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride strong 15% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium AND/OR potassium compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium 6.5mmol effervescent tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose/saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral potassium (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 10%/0.45% 10mmol/500mL infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ringer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium iodide 65 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium effervescent tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride I.V |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Normal saline + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution and 2.5% dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + 5% dextrose + 0.15% potassium hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% + saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ringers infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ringers infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ringers infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium gluconate 20meq/15mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10meq m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750 mg10 meq tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1g/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10 meq750 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/10mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.5g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 10 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 20 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/15mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Monobasic potassium phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium perchlorate 200mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium iodide 5gr/5cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium nitrate 8% paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium iodide + theophylline, anhydrous 130mg/80mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine hydrochloride + potassium iodide 8mg/150mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate- and potassium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium electrolyte |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|